Literature DB >> 8608156

Activation of human plasma cholesteryl ester transfer protein by human apolipoprotein A-IV.

L A Main1, T Ohnishi, S Yokoyama.   

Abstract

Function of apolipoprotein (apo) A-IV was studied for its role in cholesteryl ester transfer protein (CETP; lipid transfer protein, LTP) reaction between lipid microemulsions having the diameter of low density lipoprotein, being compared to apoA-I. CETP hardly catalyzed lipid transfer without apolipoproteins. ApoA-IV bound to the surface of the microemulsion in equilibrium with a similar affinity to that of other helical apolipoproteins, and activated the transfer reaction by CETP of cholesteryl ester, triacylglycerol and phosphatidylcholine between the emulsions. The rate of the transfer reaction of cholesteryl ester and triacylglycerol was directly proportional to the amount of the bound apoA-IV to the surface of the emulsion. For phosphatidylcholine, activation was less effective until 40% of total binding capacity of lipid emulsion was occupied by the apolipoprotein. Cholesteryl ester was highly preferred by CETP over triacylglycerol when equal amount of these lipids was present in the core of the apoA-IV-activated emulsion, resulting in almost no triacylglycerol transfer. However, when the emulsion has the core exclusively of triacylglycerol, triacylglycerol was transferred by CETP with the rate in the same order as that of cholesteryl ester transfer. These findings were all comparable to the results with apoA-I, and also consistent with our previous observation for other amphiphilic helical apolipoproteins such as apoA-II, E and C-III.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8608156     DOI: 10.1016/0005-2760(95)00228-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Apolipoprotein C-I binds more strongly to phospholipid/triolein/water than triolein/water interfaces: a possible model for inhibiting cholesterol ester transfer protein activity and triacylglycerol-rich lipoprotein uptake.

Authors:  Nathan L Meyers; Libo Wang; Donald M Small
Journal:  Biochemistry       Date:  2012-02-02       Impact factor: 3.162

2.  The apolipoprotein A-IV Gln360His polymorphism predicts progression of coronary artery calcification in patients with type 1 diabetes.

Authors:  A Kretowski; J E Hokanson; K McFann; G L Kinney; J K Snell-Bergeon; D M Maahs; R P Wadwa; R H Eckel; L G Ogden; S K Garg; J Li; S Cheng; H A Erlich; M Rewers
Journal:  Diabetologia       Date:  2006-06-13       Impact factor: 10.122

3.  Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1.

Authors:  Xiaoming Li; Min Xu; Fei Wang; Alison B Kohan; Michael K Haas; Qing Yang; Danwen Lou; Silvana Obici; W Sean Davidson; Patrick Tso
Journal:  J Biol Chem       Date:  2013-12-05       Impact factor: 5.157

4.  Minor allele of the APOA4 gene T347S polymorphism predisposes to obesity in postmenopausal Turkish women.

Authors:  Filiz Guclu-Geyik; Altan Onat; Neslihan Coban; Evrim Komurcu-Bayrak; Vedat Sansoy; Günay Can; Nihan Erginel-Unaltuna
Journal:  Mol Biol Rep       Date:  2012-10-25       Impact factor: 2.316

5.  The structure of human apolipoprotein A-IV as revealed by stable isotope-assisted cross-linking, molecular dynamics, and small angle x-ray scattering.

Authors:  Ryan G Walker; Xiaodi Deng; John T Melchior; Jamie Morris; Patrick Tso; Martin K Jones; Jere P Segrest; Thomas B Thompson; W Sean Davidson
Journal:  J Biol Chem       Date:  2014-01-14       Impact factor: 5.157

6.  A three-dimensional homology model of lipid-free apolipoprotein A-IV using cross-linking and mass spectrometry.

Authors:  Matthew R Tubb; R A Gangani D Silva; Jianwen Fang; Patrick Tso; W Sean Davidson
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

7.  Specific sequences in N termini of apolipoprotein A-IV modulate its anorectic effect.

Authors:  Fei Wang; Kevin J Pearson; W Sean Davidson; Patrick Tso
Journal:  Physiol Behav       Date:  2013-07-30

8.  ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT.

Authors:  Adelina Duka; Panagiotis Fotakis; Dimitra Georgiadou; Andreas Kateifides; Kalliopi Tzavlaki; Leonard von Eckardstein; Efstratios Stratikos; Dimitris Kardassis; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2012-11-06       Impact factor: 5.922

9.  The structure of dimeric apolipoprotein A-IV and its mechanism of self-association.

Authors:  Xiaodi Deng; Jamie Morris; James Dressmen; Matthew R Tubb; Patrick Tso; W Gray Jerome; W Sean Davidson; Thomas B Thompson
Journal:  Structure       Date:  2012-05-09       Impact factor: 5.006

10.  Different Functional and Structural Characteristics between ApoA-I and ApoA-4 in Lipid-Free and Reconstituted HDL State: ApoA-4 Showed Less Anti-Atherogenic Activity.

Authors:  Jeong-Ah Yoo; Eun-Young Lee; Ji Yoon Park; Seung-Taek Lee; Sihyun Ham; Kyung-Hyun Cho
Journal:  Mol Cells       Date:  2015-05-22       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.